That's about one in six people
Illinois weight-loss drug plan could cost over $200M Other states are denying coverage of the popular GLP-1 drugs due to the hefty price tag May 3, 2024 Grocers are already taking a revenue hit from the proliferation of weight-loss wonder drugs like Ozempic, Wegovy, and Mounjaro, but that trend is likely to have a greater effect in Springfield, Ill., due to a proposal to include the GLP-1 drugs in the states health insurance program
According to Gilead, patients in the Vemlidy cohort and those on the placebo who switched to open-label Vemlidy after 24 weeks showed progressive increases in the rates of virological suppression through 96 weeks
doi:10.1016/j.immuni.2012.10.002
And the reason they oppose it, on the surface is nonsensical, because they claim that administering a vaccine is something that physicians should be only doing, or only certain vaccines pharmacists can administer